Drug intelligence / Profile preview

depigmented-polymerised grass pollen extract

Development stage
Unknown
Lead developer
Inmunotek
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Subcutaneous
01

Overview

Depigmented-polymerised grass pollen extract is a chemically modified allergen preparation used for subcutaneous allergen immunotherapy (SCIT) in patients with respiratory allergies such as allergic rhinitis and allergic asthma due to sensitization to grass pollens. The process involves removing pigment molecules and polymerizing the proteins in the pollen extracts, which reduces their IgE-binding capacity while preserving T-cell reactivity. This modification aims to decrease the risk of severe allergic reactions during immunotherapy while maintaining or enhancing clinical efficacy[3][5]. The primary mechanism is immune tolerance induction by repeated exposure to modified allergens, leading to increased production of blocking antibodies (such as IgG4) and reduced sensitivity of effector cells involved in allergy. Depigmented-polymerised extracts are considered safer than native extracts and allow higher doses for improved efficacy[3][5]. These preparations are typically administered via subcutaneous injection over several years.

Other names
depigmented-polymerized grass pollen extractDPP grass pollen extractdepigmented-polymerized allergen extract (grass)allergoid (grass)
02

Targets

MHC II (Major histocompatibility complex class II receptor)

Beyond the preview

Go deeper on depigmented-polymerised grass pollen extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on depigmented-polymerised grass pollen extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call